Methods for identifying compounds that modulate enzymatic activity

Details for Australian Patent Application No. 2003216468 (hide)

Owner Sunesis Pharmaceuticals, Inc.

Inventors Erlanson, Daniel A; Hansen, Stig; McDowell, Robert S

Agent Griffith Hack

Pub. Number AU-B-2003216468

PCT Number PCT/US03/06217

PCT Pub. Number WO2003/087054

Priority 60/377,034 01.05.02 US; 10/374,499 25.02.03 US; 10/121,216 10.04.02 US

Filing date 26 February 2003

Wipo publication date 27 October 2003

Acceptance publication date 21 August 2008

International Classifications

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/377,034 01.05.02 US; 10/374,499 25.02.03 US; 10/121,216 10.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-B-2003216468

21 August 2008 Application Accepted

  Published as AU-B-2003216468

18 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216469-Assay for anti-INGAP antibodies

2003216467-A MULTISTAGE EQUALIZER THAT CORRECTS FOR LINEAR AND NONLINEAR DISTORTION IN A DIGITALLY-MODULATED SIGNAL